Sernova Corp.
TSX:SVA.TOBiotechnology
-$0.01 today
- Market cap
- $50.98M
- Beta
- 0.66
- P/E (TTM)
- -4.7
- EPS (TTM)
- -$0.03
Volume 0.55M
Average 0.12M
SVA.TO Other Financing Activities
Financing cash flows not reported separately.
Sernova Corp.TSX: SVA.TO
Other Financing Activities · Q2 FY2026 · quarter ended Apr 2026
Other financing activities turns positive
Q2 FY2026 other financing activities was CA$0, compared with -CA$43.29K a year earlier. Trailing-twelve-month other financing activities was -CA$27.02K.
Context
- Other financing activities increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other financing activities holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of -CA$6.75K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
CAD · from the cash flow
- Latest · FY2025
- (47.93K) CAD
- Year-over-year change
- -117.3%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-31 | (47.93K) | -117.3% |
| FY2024 | 2024-10-31 | 277.17K | -59.0% |
| FY2023 | 2023-10-31 | 675.39K | -95.9% |
| FY2022 | 2022-10-31 | 16.55M | +67.2% |
| FY2021 | 2021-10-31 | 9.9M | — |
Other Financing Activities vs competitors
How SVA.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.5% is the lowest of 2, against a peer median of -99.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | CA$27.02K CAD | -100.5% | — | — | |
| LTM Apr 2026 | $921.7 USD | -99.9% | — | — | |
| Peer median (excluding SVA.TO) | — | -99.9% | — | — | |
Competitors are the stored peer set for SVA.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Net Income | (6.97M) | (24.42M) | (39M) | (32.19M) | (15.74M) |
| Depreciation & Amortization | 267.2K | 440K | 445.55K | 540.28K | 342.59K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (70K) |
| Stock-Based Compensation | 218.4K | 7.45M | 3.9M | 1.75M | 2.3M |
| Change in Working Capital | 517.56K | 2.95M | 4.99M | 11.16M | 1.74M |
| Accounts Receivables | (89.8K) | (195.04K) | 229.7K | 561.85K | 175.47K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 607.35K | 3.14M | 4.76M | 10.6M | 1.56M |
| Other Non-Cash Items | (881.36K) | (838.57K) | (676.34K) | (150.48K) | 523.74K |
| Operating Cash Flow | (6.84M) | (14.42M) | (30.34M) | (18.9M) | (10.91M) |
| Capital Expenditures | (17.23K) | (329K) | (99.26K) | 0 | (3) |
| Acquisitions (Net) | 0 | 46M | 0 | 0 | 24.96K |
| Purchases of Investments | 0 | (59M) | (18.05M) | 0 | 0 |
| Sales of Investments | 0 | 13M | 52.97M | 11.08M | 0 |
| Other Investing Activities | (211.55K) | (46.01M) | (35.3K) | 35.3K | 0 |
| Investing Cash Flow | (228.78K) | (46.34M) | 34.78M | 11.12M | 24.96K |
| Debt Repayment | (28K) | (168.56K) | (171.93K) | (169.23K) | 4.94M |
| Common Stock Issued | 21.13M | 20.28M | 0 | 4.96M | 248.64K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 9.9M | 16.55M | 675.39K | 277.17K | (47.93K) |
| Financing Cash Flow | 31M | 36.66M | 503.46K | 5.07M | 5.14M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 23.92M | (24.1M) | 4.95M | (2.71M) | (5.75M) |
| Free Cash Flow | (6.86M) | (14.75M) | (30.44M) | (18.9M) | (10.91M) |
Sernova Corp.
TSX:SVA.TO
Intrinsic Alpha fair value
Locked
Current Price
$0.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.